… of antimicrobial peptides. Because the composition of the eukaryotic cell membrane and the
bacterial membrane is different, cationic antimicrobial peptides … , antimicrobial peptides can …

… peptides have so far failed to reach the market, there are continued initiatives to advance
such potential therapeutics … costs for peptides; allowing entry into therapeutic areas previously …

… antimicrobial peptides (AMPs) increased significantly during recent years (figure 1). More
than 700 antimicrobial peptides … synthesised and ribosomally synthesised peptides.[1] The …

… on the development of synthetic antimicrobial peptides (AMPs) with lower … therapeutic
options for the treatment of SSTIs and wounds as they show a broad spectrum of antimicrobial …

… Intense nonclinical and clinical research is today ongoing to evaluate antimicrobial peptides
(AMPs) as potential next-generation antibiotics. Currently, multiple AMPs are assessed in …

Histatins are a group of antimicrobial peptides, found in the saliva of man and some higher
primates, which possess antifungal properties. Histatins bind to a receptor on the fungal cell …

… This review details the therapeutic potential of peptide-based antimicrobials, as well as
the challenges needed to overcome in order for clinical translation. We explore the proposed …

Antimicrobial peptides (AMPs) are endogenous polypeptides produced by multicellular
organisms in order to protect a host from pathogenic microbes. AMPs are also defined as host …

… in recent years to bring the potential of this class of compounds into the clinic. The term
cationic antimicrobial peptide is classically applied to a peptide with direct antibiotic activity, …

… and updated overview of studies addressing the therapeutic potential of AMPs in mixed
infections, highlighting the opportunities offered by this class of antimicrobials in the fight against …